| Maurice Henry Van Strickland, MD | |
|
10021 W 21st St N, Wichita, KS 67205-1831 | |
| (316) 722-4800 | |
| (316) 722-5117 |
| Full Name | Maurice Henry Van Strickland |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 50 Years |
| Location | 10021 W 21st St N, Wichita, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962469262 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KI0005X | Allergy & Immunology - Clinical & Laboratory Immunology | 04-18175 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wesley Medical Center | Wichita, KS | Hospital |
| Entity Name | Mhv Strickland Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528265543 PECOS PAC ID: 9830278795 Enrollment ID: O20080502000405 |
News Archive
New research has shown that a diet high in beta carotene, vitamins C and E, and zinc is associated with a substantially reduced risk of age-related macular degeneration in elderly people.
NovaSterilis Inc., a leader in the development and commercialization of supercritical carbon dioxide technology, has been granted US Patent 7,919,096. The patent, dated April 5th 2011, is entitled "Inactivating Organisms Using Carbon Dioxide At or Near Supercritical Pressure and Temperature Conditions."
In this Bloomberg Businessweek opinion piece, Charles Kenny, a fellow at the Center for Global Development and the New America Foundation, examines the global obesity epidemic, writing, "It may seem strange to be worried about too much food when the United Nations suggests that, as the planet's population continues to expand, about one billion people may still be undernourished," but "growing obesity in poorer countries is a sign of a historic global tipping point."
Biogen Idec and Portola Pharmaceuticals, Inc. today announced that they have entered into an exclusive, worldwide collaboration and license agreement under which both companies will develop and commercialize highly selective, novel oral Syk inhibitors for the treatment of various autoimmune and inflammatory diseases, including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).
One day soon a biosensing nanodevice developed by Arizona State University researcher Wayne Frasch may eliminate long lines at airport security checkpoints and revolutionize health screenings for diseases like anthrax, cancer and antibiotic resistant Staphylococcus aureus (MRSA).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maurice Henry Van Strickland, MD 10021 W 21st St N, Wichita, KS 67205-1831 Ph: (316) 722-4800 | Maurice Henry Van Strickland, MD 10021 W 21st St N, Wichita, KS 67205-1831 Ph: (316) 722-4800 |
News Archive
New research has shown that a diet high in beta carotene, vitamins C and E, and zinc is associated with a substantially reduced risk of age-related macular degeneration in elderly people.
NovaSterilis Inc., a leader in the development and commercialization of supercritical carbon dioxide technology, has been granted US Patent 7,919,096. The patent, dated April 5th 2011, is entitled "Inactivating Organisms Using Carbon Dioxide At or Near Supercritical Pressure and Temperature Conditions."
In this Bloomberg Businessweek opinion piece, Charles Kenny, a fellow at the Center for Global Development and the New America Foundation, examines the global obesity epidemic, writing, "It may seem strange to be worried about too much food when the United Nations suggests that, as the planet's population continues to expand, about one billion people may still be undernourished," but "growing obesity in poorer countries is a sign of a historic global tipping point."
Biogen Idec and Portola Pharmaceuticals, Inc. today announced that they have entered into an exclusive, worldwide collaboration and license agreement under which both companies will develop and commercialize highly selective, novel oral Syk inhibitors for the treatment of various autoimmune and inflammatory diseases, including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).
One day soon a biosensing nanodevice developed by Arizona State University researcher Wayne Frasch may eliminate long lines at airport security checkpoints and revolutionize health screenings for diseases like anthrax, cancer and antibiotic resistant Staphylococcus aureus (MRSA).
› Verified 7 days ago
Dr. Thomas F Rosenberg, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 8535 E 21st St N, Wichita, KS 67206 Phone: 316-609-2385 Fax: 316-609-2346 | |
Dr. Seth A Schneider, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 8110 E 32nd St N, Ste 170, Wichita, KS 67226 Phone: 316-634-0020 Fax: 316-634-2224 |